Delivery Order SPE2DB22D1052-SPE2DB25FU9ED
Award Date
5/16/25
Potential Completion Date
6/9/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Esbriet 801 mg tablets. The contract has a firm-fixed price of $3,311.50 and a completion date of November 5, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Esbriet 801 mg tablets. The total ceiling value of the contract is $3,311.50, and the ultimate completion date is October 11, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor responsible for providing these...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Esbriet 801 mg tablets. The contract is a firm-fixed price agreement with a ceiling value of $13,246.00 and a completion date of August 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the supply of ESBRIET 267 MG TABLET 270S, a prescription medication. The contract has an ultimate completion date of May 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a potential value of $9,934.50 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp will provide Esbriet 801 mg tablets to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,623.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Esbriet 801 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esbriet 267 mg tablets, a medication used to treat a specific medical condition. The contract has a ceiling value of $6,851.90 and is a firm fixed-price delivery order, with a performance period ending on May 22, 2025. The contract is not set-aside and was awarded on May 1,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,185 units of the pharmaceutical product Esbriet 267 mg tablet. The contract has a ceiling value of $3,311.50 and a period of performance through April 25, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESBRIET 801 MG TABLET 90S. The contract has a firm fixed price of $3,425.95 and a period of performance through June 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $6,623.00, is for the supply of the medication Esbriet (pirfenidone) 801 mg tablets. This contract is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides...